| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0009 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.49 | 0.002 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.002 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |